Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
Tune in to this powerful show. Darnisha Grant Harrison is one of the first African American females to serve as founder, president and CEO of a pharmaceutical company in the U.S. She does not focus on vaccines. She focuses on CURES.
Ennaid Therapeutics is creating disruptive innovation to safely & rapidly develop cures for mosquito-borne, emerging infectious diseases by developing first-to-market, proprietary therapeutics (not vaccines) for nearly one billion people worldwide who contract the following: dengue virus (the world's fastest growing pandemic), as well as, West Nile virus, chikungunya, yellow fever, tick borne encephalitis, European encephalitis, Japanese encephalitis, Kyasanur Forest virus, zikva virus & non mosquito-borne, hepatitis c virus. Using their flavivirus fusion inhibitor technology that inhibits these viruses by >99%, & employing an industry-proven, fast-track development program, their cures will be on the market in 4-6 years, causing an unprecedented paradigm shift in global health.
www.ennaidthera.com
